Key EventCompany dispatched a letter providing the web-link to access the Annual Report 2025-26 to shareholders who have not registered their email addresses.
ImpactShareholders must update their email and KYC details to receive future communications and access the annual report online.Sign up to read impact
Key Event33rd AGM scheduled for September 21, 2026, via video conferencing, with voting on director reappointments and FY 2025-26 financials.
ImpactThe company is transitioning from API manufacturing to a diversified pharmaceutical platform with growing formulation and oncology capabilities, supported by a strong balance sheet and export growth.Sign up to read impact
Key EventBajaj Healthcare Limited filed its Business Responsibility and Sustainability Report (BRSR) for FY 2025-26 with SEBI, detailing ESG performance and sustainability initiatives.
ImpactThe BRSR report demonstrates Bajaj Healthcare's structured approach to ESG compliance, risk mitigation, and sustainable growth, offering investors visibility into its environmental stewardship, governance, and stakeholder engagement frameworks.Sign up to read impact
Key Event33rd AGM scheduled for 21 September 2026 with e-voting from 17-20 September 2026
ImpactShareholders must register by 14 September 2026 to vote electronically; special resolutions require approval for key governance changes.Sign up to read impact
Key EventBajaj Healthcare receives DCGI approval for Cenobamate API and tablets
ImpactThis approval unlocks a new revenue stream in the CNS therapeutic area and establishes first-mover advantage in India's epilepsy treatment market.Sign up to read impact